We are live on ! Find out more
MDT icon

Medtronic

1,280 hedge funds and large institutions have $98.3B invested in Medtronic in 2017 Q2 according to their latest regulatory filings, with 94 funds opening new positions, 467 increasing their positions, 542 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more funds holding in top 10

Funds holding in top 10: 4763 (+16)

13% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 83

8% more capital invested

Capital invested by funds: $91B → $98.3B (+$7.29B)

0% less funds holding

Funds holding: 1,2831,280 (-3)

1.05% less ownership

Funds ownership: 82.51%81.46% (-1%)

14% less repeat investments, than reductions

Existing positions increased: 467 | Existing positions reduced: 542

23% less call options, than puts

Call options by funds: $357M | Put options by funds: $462M

Holders
1,280
Holders Change
-3
Holders Change %
-0.23%
% of All Funds
31.91%
Holding in Top 10
63
Holding in Top 10 Change
+16
Holding in Top 10 Change %
+34.04%
% of All Funds
1.57%
New
94
Increased
467
Reduced
542
Closed
83
Calls
$357M
Puts
$462M
Net Calls
-$104M
Net Calls Change
-$4.47M

MDT Hedge Fund Activity: Q2 2017 in Review

1,280 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q2 2017, worth a combined $98.3B — up 8% from $91B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new MDT positions and 83 closed out — a net gain of 11 holders — while 467 added to existing stakes and 542 trimmed.

The largest buyer was Lazard Asset Management, adding an estimated $566M. The largest seller was Wellington Management Group, cutting an estimated $878M.

  • 1,280 institutional investors held Medtronic (MDT) as of Q2 2017, down from 1,283 in Q1 2017.
  • Funds reported $98.3B of Medtronic stock for Q2 2017, up 8% quarter-over-quarter.
  • 94 funds opened new Medtronic positions in Q2 2017 and 83 closed out, a net change of +11 holders.
  • The largest Medtronic buyer in Q2 2017 was Lazard Asset Management, an estimated $566M added.
  • The largest Medtronic seller in Q2 2017 was Wellington Management Group, an estimated $878M sold.

Based on aggregated 13F filings for Q2 2017.